PR-104 is a dinitrobenzamide mustard currently in clinical trial as a hypoxia-activated prodrug. Its major metabolite, PR-104A, is metabolized to the corresponding hydroxylamine (PR-104H) and amine (PR-104M), resulting in activation of the nitrogen mustard moiety. We characterize DNA damage responsible for cytotoxicity of PR-104A by comparing sensitivity of repair-defective hamster Chinese hamster ovary cell lines with their repair-competent counterparts. PR-104H showed a repair profile similar to the reference DNA cross-linking agents chlorambucil and mitomycin C, with marked hypersensitivity of XPF −/− , ERCC1
Introduction
Hypoxia is a ubiquitous feature of tumors and is a negative prognostic indicator in many contexts (1) (2) (3) . The therapeutic problems that tumor hypoxia poses are multifactorial, including radioresistance, inaccessibility of cells distant from blood vessels to drugs, and molecular changes that increase multidrug resistance, invasiveness, and metastasis (4) . Collectively, these effects of hypoxia can limit outcomes of all major therapeutic modalities, as illustrated by decreased overall survival following surgical resection of osteosarcomas as a result of a higher rate of distant metastasis from more hypoxic primary tumors (5) , decreased local control of hypoxic head and neck squamous cell carcinomas by radiotherapy (6) (7) (8) , and poorer response rates and disease-free survival in anthracycline-based chemotherapy of breast tumors with high expression of hypoxia-inducible factor-1 and other hypoxia markers (9) .
The importance of hypoxia as a therapeutic target has led to the development of hypoxia-activated prodrugs (also called bioreductive drugs or hypoxic cytotoxins) that are metabolized to active cytotoxins by pathways that are inhibited by oxygen (4, (10) (11) (12) (13) (14) . One of these is PR-104 (see Fig. 1A for chemical structures), a phosphate ester pre-prodrug currently in clinical trial (15, 16) , which is converted systemically to the corresponding alcohol PR-104A; the latter is metabolized selectively under hypoxia to the hydroxylamine PR-104H and amine PR-104M by reduction of the nitro group para to the mustard moiety. This biotransformation of the electron withdrawing nitro group to electron-donating hydroxylamine or amine acts as a molecular switch to increase the alkylating reactivity of the latent nitrogen mustard moiety of dinitrobenzamide mustards such as PR-104A (15, 17, 18) .
Thus, based on its design, the molecular mechanism of the hypoxic cytotoxicity of PR-104A is expected to be formation of DNA interstrand cross-links (ICL). Consistent with this, one of its active metabolites, PR-104H, is ∼25-fold more potent against an XPF/ERCC4 mutant cell line (UV41) than the corresponding cell line in which 90% of XPF activity is restored (15) . This differential was similar to that for chlorambucil (15) and consistent with a role for ICL. Further, hypoxia-selective DNA cross-linking by PR-104A itself has been shown in human tumor cells using the comet assay (15, 19) . However, there are multiple mechanisms of cytotoxicity of nitroaromatic compounds that might contribute to cell killing by PR-104A in certain contexts, including redox cycling of a nitro group to generate reactive oxygen species, formation of reactive nitroso or hydroxylamine moieties, or (in the case of the dinitrobenzamide mustards) the formation of DNA monoadducts by PR-104A itself or its reduction products.
This suggested the need for a more critical evaluation of mechanism of action, which we undertake here by examining a range of PR-104A analogues (including half mustards incapable of DNA cross-linking by the mechanism proposed for PR-104A; Fig. 1A ) in a panel of repair-defective cell lines. The repair-defective cells are all derived from the Chinese hamster ovary (CHO) fibroblast line AA8 and interrogate the roles of nucleotide excision repair (NER), nonhomologous end joining (NHEJ), and homologous recombination repair (HRR) in the aerobic and hypoxic cytotoxicity of PR-104A. During this study, we observed that mutations in XPF had a smaller effect on PR-104A sensitivity than expected, so we also examined mutations in ERCC1. These two genes code for a heterodimeric endonuclease with a critical, if controversial, role in the "unhooking" of ICL (20) (21) (22) . We also examine the consequences of modulating the rate of nitroreduction of PR-104A by overexpressing a truncated form of human NADPH:cytochrome P450 oxidoreductase (CYPOR), known to be a major PR-104A reductase in hypoxic cells (23) in HRR-defective and HRR-competent cell lines. Together, these approaches explore the interaction between reductase expression, hypoxia, and DNA repair pathways, which are expected to be key determinants of sensitivity of tumor cells to this novel prodrug.
Materials and Methods

Compounds
All compounds had a purity of at least 95% by high-performance liquid chromatography and were stored as stock solutions at −80°C. 2-((2-Bromoethyl)-2-{[(2-hydroxyethyl) amino] carbonyl}-4,6-dinitroanilino) ethyl methanesulfonate (PR-104A) was synthesized as previously described (24) and 100 mmol/L stock solutions were stored in DMSO. PR-104H was prepared by zinc dust reduction of PR-104A as previously described (15) except that a Pd catalyst Bactron anaerobic chamber (Sheldon Manufacturing Inc) was used, which improved yield. PR-104H was purified by preparative high-performance liquid chromatography and stored in acetonitrile. Tetradueterated PR-104H (PR-104H-d4) was synthesized in the same manner from PR-104A-d4 (25) . PR-104M was synthesized from PR-104A by regioselective reduction of the nitro group para to the mustard using 10% Pd/C and ammonium formate in methanol. Treatment of unstable PR-104M with trifluoroacetic anhydride gave the stable N,O-ditrifluoroacetyl derivative, which was subjected to an in-depth nuclear magnetic resonance spectroscopic investigation (  1 H-13 C HMBC,  1 H-15 N HMBC,  1 H-13 C HSQC,  COSY) , confirming the structure of PR-104M. The half mustard analogues of PR-104A were synthesized by reaction of 2-chloro-N-(2-hydroxyethyl)-3,5-dinitrobenzamide (24) with aziridine to give 2-(1-aziridinyl)-N-(2-hydroxyethyl)-3,5-dinitrobenzamide, which was subsequently treated with aqueous hydrobromic acid and aqueous methanesulfonic acid to give 1 and 2, respectively. The corresponding diethyl compound (3) was prepared by reaction of 2-chloro-N-(2-hydroxyethyl)-3,5-dinitrobenzamide with diethylamine. The structures of 1, 2, and 3 were confirmed by 1 H nuclear magnetic resonance spectroscopy and elemental analysis. Mitomycin C (Sigma-Aldrich) stock solutions (10 mmol/L in ethanol) were stored at −80°C. Chlorambucil was from Sigma-Aldrich. Its half mustard was synthesized as reported previously (26) and dissolved in DMSO to 600 mmol/L. Nitracrine was synthesized as previously described (27) 2 -terminal reticular membrane anchor, was prepared and a sCYPOR expression plasmid (F527-LMWp450R) was used to transfect the 51D −/− and 51D +/+ cell lines using FuGENE 6 transfection reagent (Roche Diagnostics) essentially as described (36) . The stable lines 51D −/− sCYPOR (clones 1 and 2) and 51D +/+ sCYPOR (clones 1 and 2) were selected and maintained in 40 and 50 μmol/L of puromycin, respectively. Puromycin was withdrawn 1 d before cells were used in experiments.
CYPOR Western Blot Analysis Cells were harvested by trypsinization of subconfluent monolayers from T-flasks and counted using an electronic particle counter (Z2 Coulter Particle Analyzer, Beckman Coulter), and 10 6 cells were collected by centrifugation for 15 s. Pellets were lysed by adding 50 μL Laemmli sample buffer (Bio-Rad) containing 5% 2-mercaptoethanol, lysates were boiled at 95°C for 5 min and centrifuged for 3 min, and supernatants were loaded onto 4% to 10% SDSpolyacrylamide gels that were electrophoresed for 1.5 h. Proteins were electrophoretically transferred onto 0.22 μm nitrocellulose and blocked with 5% fat-free milk in PBS-0.05% Tween 20 at room temperature for 2 h and probed with primary antibodies [goat anti-rat CYPOR (Daiichi Pure Chemicals) or mouse anti-actin (Chemicon International) as loading control, both at 1:10,000] in PBS-Tween 20/5% nonfat milk overnight at 4°C. The blots were washed with PBS-0.05% Tween 20 for 5 min three times, incubated with secondary antibodies (rabbit anti-goat IgG-horseradish peroxidase and goat anti-mouse IgG-horseradish peroxidase from Santa Cruz Biotechnology, both at 1:10,000) at room temperature for 1 h, washed again in PBS-0.05% Tween 20 for 5 min three times, and visualized by enhanced chemiluminescence using an ImageReader LAS-3000 (Fujifilm). Band densities were determined using ImageJ software (version 1.37).
CYPOR Enzyme Activity
The activity of CYPOR in the cell lines was measured by spectrophotometric assay as the cyanide-resistant, NADPHdependent reduction of cytochrome c in S-9 fractions as described previously (37) . Total protein concentrations were measured using the bicinchoninic acid assay (38) .
Inhibition of Cell Proliferation In vitro Cells were harvested as above, seeded into 96-well plates (typically 400 cells/0.1 mL), allowed to attach for 2 h, and exposed to compounds for 4 h under aerobic or anoxic conditions as detailed elsewhere (39) . Anoxic cultures were exposed in a Bactron anaerobic chamber using medium supplemented with 10% FCS, 10 mmol/L glucose, and 200 μmol/L 2′-deoxycytidine, which had been equilibrated (along with the 96-well plates) in the chamber for at least 3 d to remove oxygen. Cultures were then grown in an aerobic 5% CO 2 incubator for 4 to 5 d before staining with sulforhodamine B. The IC 50 was determined by interpolation as the drug concentration reducing staining to 50% of controls on the same plate. The hypoxic cytotoxicity ratio (HCR) was determined as the intraexperiment ratio (aerobic IC 50 )/ (anoxic IC 50 ), and the hypersensitivity factor (HF) was determined as the intraexperiment ratio (IC 50 for repaircompetent line)/(IC 50 for repair mutant). Differences between cell lines, and between aerobic and anoxic exposure, were tested for significance using Student's t test.
Clonogenic Cell Survival Cells were seeded into 96-well plates as for IC 50 assays, except that each well received 3 × 10 5 cells in 150 μL medium, and were exposed to drugs for 4 h in the same manner. Cells were then rinsed with 100 μL PBS and harvested into microtubes (Titertube, Bio-Rad) using 100 μL trypsin followed by two rinses with 200 μL medium. One 3-fold and three 10-fold serial dilutions were made in microtubes using a 12-channel pipette, and transfer pipettes were used to plate 10 2 to 10 5 cells into 60-mm cell culture dishes containing 5 mL culture medium (αMEM with 5% fetal bovine serum). The dishes were incubated at 37°C for 14 d and stained with methylene blue (2 g/L in 50% aqueous ethanol), and colonies with >50 cells were counted. Surviving fraction was calculated as the ratio of colonies from treated/control wells.
Liquid Chromatography-Tandem Mass Spectrometry Assay of PR-104A Metabolism Subconfluent monolayers were harvested from T75 flasks, centrifuged, and resuspended at 1.5 × 10 6 cells/mL in 1.2 mL aliquots of oxic or anoxic medium, the latter in an anaerobic chamber as above. Cells were plated in 24-well plates to give 5 × 10 5 cells per well in 0.35 mL, incubated for 2 h at 37°C before addition of a 50 μL of the same medium containing PR-104A to give a final concentration of 100 μmol/L, and then returned to the incubator for 1 h. Samples were then processed rapidly on wet ice. Medium (400 μL) was transferred into a microcentrifuge tube and the attached cells were extracted with 800 μL ice-cold methanol containing PR-104H-d4 internal standard before combining with the extracellular medium and storing at −80°C. Before liquid chromatography-tandem mass spectrometry (LC/MS/MS), samples were centrifuged (13,000 × g, 5 min, 4°C) and 30 μL were diluted with an equal volume of purified water. Samples (25 μL) were analyzed using an Agilent 1200 high-performance liquid chromatography (Agilent Technologies) interfaced with a triple quadrupole mass spectrometer (LC/ MS/MS, model 6410). Separation was done on an Alltima C8 column (150 × 2.1-mm inner diameter, 5-μm particle size; Alltech) with a flow rate of 0.4 mL/min at 25°C. The mobile phase comprised a gradient of acetonitrile and water. The MS interface was a combined electrospray-atmospheric pressure chemical ionization (multimode) source operated in positive mode with the following parameters: fragmentor, 120 V; capillary voltage, 3 kV; nebulizer pressure, 60 p.s.i.; gas temperature, 350°C; vaporizer temperature, 225°C; auxiliary drying gas flow, 5.5 L/min; corona current positive, 3 μA; collision energy, 15 V. Multiple reaction monitoring was used with the following ion transitions: PR-104H (485 > 389), PR-104H-d4 (491 > 395), and PR-104M (469 > 373). Data were collected and analyzed using Masshunter software. PR-104H was quantified by integration of the peak area ratio PR-104H/PR-104H-d4 and PR-104M using the PR-104H calibration curve after applying a correction factor of 1.73 for the higher detection efficiency of PR-104M than PR-104H under these conditions (19) .
Results
Aerobic and Anoxic Cytotoxicity of PR-104A and Analogues
The antiproliferative activity of PR-104A and related compounds was compared using the wild-type CHO line AA8 following 4-hour drug exposure under aerobic or anoxic conditions (Fig. 1B) . PR-104A itself showed modest but significant selectivity for anoxic cells (HCR = 2.74 ± 0.23, mean and SE), whereas its major reduced metabolite, the hydroxylamine PR-104H, was more potent than PR-104A under aerobic conditions but with an HCR of unity (0.97 ± 0.09). This is consistent with hypoxic selectivity of PR-104A being due to its activation by nitroreduction under hypoxia (15) . In contrast, the half mustard analogues (1 and 2) were less potent than PR-104A and showed higher activity against aerobic rather than anoxic cells (HCR < 1; P = 0.001 for 1, P = 0.005 for 2). The nonmustard diethyl analogue (3) also showed distinct selectivity for aerobic cells, although a ratio could not be established because of its lack of activity at the solubility limit under hypoxia. The oxic selectivity of compounds 1, 2, and 3, each lacking a bifunctional nitrogen mustard moiety and therefore presumably incapable of DNA interstrand cross-linking, suggested the likely involvement of redox cycling of one of the nitro groups in their aerobic cytotoxicity.
To clarify the role of DNA ICLs in the cytotoxicity of PR-104A, we evaluated its antiproliferative activity against UV41 cells (an AA8 subline with a loss of function mutation in XPF) and a stable transfectant (41cER40.1) in which XPF activity had been restored ( Fig. 2A) . Under both aerobic and anoxic conditions, the UV41 line showed significant hypersensitivity to PR-104A, but the HFs were only 4.4 ± 0.4 under aerobic conditions and 8.3 ± 1.1 under anoxia. These HF values were much less than for the reference DNA cross-linking agent chlorambucil in the same experiments ( Fig. 2A; oxic HF, 29 ± 3; anoxic HF, 51 ± 15). Additional studies using clonogenic survival assays (Fig. 2B) The relative insensitivity of XPF-defective cells to PR-104A raised the question as to whether ICLs from PR-104A are processed in a different manner to ICLs from chlorambucil or whether PR-104A might also kill cells through other mechanisms. We therefore compared PR-104A, analogues, and reference compounds using a panel of repair-defective mutants derived from AA8 cells; absolute IC 50 values and HF ratios are tabulated for all compounds and cell lines in Supplementary Table S1 , 4 and key findings are illustrated in Fig. 3 . As expected, chlorambucil showed equal activity against XPF-and ERCC1-null mutants (UV41 and UV4, respectively) but HF values of only ∼2 against the ERCC2/XPD mutant (UV5) and no increased activity against the NHEJdeficient DNA-PK CS mutant cell line V3 (Fig. 3A) . A Rad51D knockout from AA8 cells has previously been shown to be Figure 1 . A, structures of PR-104, its metabolites, and related compounds. PR-104 is converted systemically by phosphatases to the corresponding alcohol, PR-104A, which is metabolized by reduction to the hydroxylamine PR-104H and amine PR-104M selectively under hypoxic conditions or oxidatively to the half mustards (1) and (2) 
defective in HRR and hypersensitive to the cross-linking agent mitomycin C (35) . We confirmed the hypersensitivity of this line to mitomycin C, which was similar to that for ERCC1 −/− UV4 cells (Supplementary Table S1 ) 4 and showed that the Rad51D mutant had the same marked sensitivity to chlorambucil as the XPF and ERCC1 mutants (∼30-fold; Fig. 3A) . Importantly, the PR-104A active metabolite PR-104H showed a very similar profile to chlorambucil across the panel, showing that cross-links arising from reduction of PR-104A are recognized and processed in a similar manner to chlorambucil cross-links (Fig. 3B) . The repair profiles for chlorambucil and PR-104H were essentially unchanged whether exposure occurred under aerobic or anoxic conditions. PR-104A showed a qualitatively similar (but attenuated) pattern of HF values to chlorambucil and PR-104H under oxic conditions and significantly higher HF values under anoxia (Fig. 3C ), although these were still less than for the reference cross-linking agents.
One non-ICL contributor to PR-104A cytotoxicity could be monoalkylation by unreduced PR-104A itself. To test this, we evaluated the repair profile of the monofunctional half mustard metabolites of PR-104A (1 and 2) as models for monoalkylation by PR-104A. These showed HF values of unity against all cell line pairs evaluated (Supplementary  Table S1 ), 4 including the ERCC2 mutant UV5 (Fig. 3D) , which is moderately hypersensitive to bulky monoadducts repaired by nucleotide excision repair (40) . We confirmed the known (41) hypersensitivity of UV5 cells to the hypoxia-activated monoalkylator nitracrine (Supplementary Table S1 ) 4 and showed the ability of these ERCC2 −/− cells to detect monoadducts from the half mustard analogue of chlorambucil (4), which gave similar HF values (∼5) against both ERCC1 and ERCC2 mutants (Fig. 3D) . These results suggest that the toxicity of the PR-104A half mustards is not due to monoalkylation, which also seems not to contribute to the toxicity of PR-104A given the lack of hypersensitivity of UV5 cells to this agent under aerobic conditions (Fig. 3C) .
Expression of Truncated CYPOR Increases Anoxic Metabolism of PR-104A
The above results suggest that the lower-than-expected hypersensitivity to PR-104A of cell lines defective in ICL repair is due to inefficient metabolic reduction of the prodrug in AA8 cells, even under anoxic conditions, which would account for the low HFs if an ICL-independent mechanism of cytotoxicity then contributes. To test this, we expressed human CYPOR (EC 1.
1.2.4), a known PR-104A reductase (23), in Rad51D
−/− and Rad51D +/+ cells. Although human CYPOR has been expressed in CHO cells previously (42) , transfection with a bicistronic plasmid we have used successfully with human cell lines (23) provided puromycin-resistant clones with unexpectedly low (∼2-fold) elevation in CYPOR enzyme activity (as measured by cytochrome c reduction; data not shown). To obviate possible limitations of subcellular processing and membrane localization, we then prepared a truncated form of the gene (sCYPOR), encoding a soluble polypeptide lacking the NH 2 -terminal hydrophobic tail (Δ amino acids 1-60), which harbors the endoplasmic reticulum localization Table S2 ). 4 Expression of sCYPOR provided a ∼5-fold increase in enzyme activity assessed as cytochrome c reduction (Fig. 4B) . The sCYPOR-expressing clones showed little change in aerobic metabolism of PR-104A to its reduced metabolites (Fig. 4C ) but a marked increase in PR-104A reductive metabolism under anoxia with levels of reduced metabolites in the sCYPOR clones similar to human SiHa cells (Fig. 4D) . Notably, the steady-state levels of the amine metabolite PR-104M were higher than the hydroxylamine PR-104H in all the CHO cell lines, in contrast to SiHa in which PR-104H levels were higher than PR-104M as reported previously (15) and confirmed recently with other human tumor cell lines (19) . Given that PR-104M is the major reduced metabolite in the AA8-derived cell lines, we compared its antiproliferative potency with that of PR-104H; PR-104M was slightly more potent than the hydroxylamine against AA8, UV4, and UV5 cells but had HF ratios indistinguishable from PR-104H (Supplementary Table S1 ). 4 Thus, both reduced metabolites seem to cause cell killing through DNA cross-linking.
sCYPOR Expression Increases PR-104A Anoxic Cytotoxicity and Its Dependence on Rad51D
We next evaluated the PR-104A sensitivity of the sCY-POR-expressing stable transfectants, and their Rad51D +/+ and Rad51D −/− parental lines, in IC 50 assays. First, we checked that the sCYPOR-expressing clones in the HRRdefective and HRR-competent background did not have altered sensitivity to PR-104H under either oxic (Fig. 5A) or anoxic (Fig. 5B) conditions. Chlorambucil sensitivity was also unaffected by sCYPOR expression in these clones (Supplementary Fig. S1 ). 4 Expression of sCYPOR had only a minor sensitizing effect to PR-104A under oxic conditions, and importantly, the oxic HF values (IC 50 for Rad51D +/+ / Rad51D −/− ) were not increased by sCYPOR expression (Fig. 5C ). In contrast, under anoxia, the increased reductase activity selectively sensitized to PR-104A in the HRR-defective background, raising the HF from 8.7 ± 0.8 to 19.0 ± 1.1 (Fig. 5D) , a difference that was highly significant (P < 0.001). In these experiments, PR-104A was more potent under anoxia than PR-104H itself, presumably reflecting greater cytotoxicity when this relatively hydrophilic metabolite is generated intracellularly rather than added to the culture medium.
The increased HF in cell lines with high CYPOR activity was confirmed by clonogenic assay using one of each of the sCYPOR-expressing clones following 4-hour anoxic exposure to PR-104A (Fig. 6 ). This showed that both increased CYPOR activity or suppression of HRR individually increase anoxic sensitivity to PR-104A, but the HF ratio (calculated at a surviving fraction of 0.1) was significantly (P = 0.005) increased from 18.3 ± 1.4 in the low CYPOR cell line pair to 31.3 ± 1.4 in the high CYPOR cell line pair. Thus, the HRR repair phenotype had a larger effect on cytotoxicity when CYPOR activity was high.
Discussion
This study shows the interaction between three determinants of cellular sensitivity to the prodrug PR-104A (hypoxia, repair phenotype, and reductase expression), each of conditions. HFs were calculated by pooling the data for the two independent sCYPOR-expressing clones in the Rad51D knockout and restored backgrounds.
which is likely to play a key role in its therapeutic activity in humans. PR-104A was designed to be activated by selective reduction in the absence of oxygen and shows significant selectivity for AA8 cells under anoxia, although the HCR is only 2.7 (Fig. 1B) . This is less than the HCR values for human tumor cell lines, which show a range of 6 to 200 using the same IC 50 assay (15) . This low hypoxic selectivity reflects a lack of hypoxic PR-104A reductase activity (Fig. 4D) , with steady-state levels of the reduced metabolites PR-104H and PR-104M ∼36-fold and ∼5-fold lower, respectively, in the AA8-derived cell lines (averaging 51D −/− and 51D +/+ values) than in human SiHa cells. This difference in PR-104A reductase activity was greater than that between CYPOR enzyme activity or protein levels ( Fig. 4A and B) , consistent with the previous demonstration that CYPOR is not the sole hypoxic PR-104A reductase in SiHa cells (23) .
Expression of a truncated human CYPOR gene (sCYPOR) restored PR-104A hypoxic reductase activity in CHO cells to levels similar to SiHa cells and sensitized HRR-competent 51D +/+ cells to PR-104A to a greater extent under anoxia than under aerobic conditions (as seen by comparison of Fig. 5C and D) . This increased reductase activity raised the HCR to 18 and 16 for the two 51D +/+ sCYPOR clones, which is similar to the ratio of 13-fold for SiHa (15) . Notably, the HCR was increased even further, to 54 and 34, by sCYPOR expression in the isogenic HRR-defective 51D −/− clones as seen in Fig. 5C and D. The differential sensitization to hypoxic toxicity of PR-104A by sCYPOR is also shown by the higher HF values for Rad51D-null than Rad51D +/+ cells under anoxia using either IC 50 (Fig. 5D) or clonogenic (Fig. 6) 50 , 185 μmol/L).
The present study confirms DNA ICL as important in the cytotoxicity of PR-104A, especially under hypoxia. The hypersensitivity of cells with defective XPF, ERCC1, and Rad51D to PR-104A parallels that of chlorambucil, which showed the same repair profile as the PR-104A active metabolite PR-104H. PR-104M (the cytotoxicity of which is reported for the first time in this study) and mitomycin C showed a similar pattern in the more limited set of cell lines in which they were investigated (Supplementary Table S1 ). 4 ERCC1 and XPF mutants have previously been reported to be ∼90-fold sensitive to mitomycin C (30), which is very similar to the 80-fold sensitivity of the Rad51D mutant described recently (35) . These observations support current cross-link repair models (22, 43, 44) in which unhooking of ICL by ERCC1-XPF and restarting of DNA synthesis at broken replication forks by HRR are sequential and essential steps in ICL repair. The present study shows that repair of PR-104A-induced ICL follows this same pathway; its lower-than-expected HF values are overcome by hypoxia and expression of sCYPOR, showing that they reflect a lack of metabolic activation of the prodrug in CHO cell lines rather than formation of a DNA lesion that is processed differently from other ICL. No change in sensitivity on expression of sCYPOR was observed with PR-104H ( Fig. 5A and B) or chlorambucil ( Supplementary Fig. S1 ), 4 confirming that the altered HF ratios for PR-104A in the sCYPOR-expressing clones are not a result of chance selection of a subline with altered intrinsic sensitivity to a nitrogen mustard or to offtarget effects of sCYPOR.
An obvious corollary of low HF values in the AA8 cell line panel is that there is a separate ICL-unrelated mechanism of PR-104A cytotoxicity in cell lines with low reductase activity (i.e., aerobic cells and/or cells with low reductase expression). A similar conclusion has been reached from the recent demonstration that some human tumor cell lines do not form ICL, measured with the alkaline comet assay, following aerobic exposure to PR-104A at concentrations that cause clonogenic cell killing (19) . Several possibilities can be considered for this ICL-independent mechanism of cytotoxicity. One is the oxidative metabolism of the nitrogen mustard moiety of PR-104A to the corresponding half mustards as reported in mice (45) and in liver S9 preparations (46) . The resulting half mustards are less toxic than PR-104A itself (Fig. 1B) , as expected given their inability to form ICL, but this oxidative dealkylation of mustards is known to release reactive and toxic acetaldehydes (47) , which could contribute to PR-104A cytotoxicity. Although a theoretical possibility, we have not been able to detect half mustard formation from PR-104A in AA8 cells (data not shown), which presumably reflects their low cytochrome P450 enzyme activity.
A second potential mechanism of cytotoxicity is DNA monoalkylation by unreduced PR-104A itself. The bromo and mesylate mustard leaving groups of PR-104A are displaced by chloride ion in physiologic solutions but at a very slow rate compared with PR-104H (15) . This difference confirms the expected increase in nitrogen mustard reactivity on reduction of the para nitro group (48, 49) but also indicates that PR-104A itself does have weak residual alkylating activity. This might generate DNA monoadducts, whereas cross-linking by the second arm of the mustard monoadducts would be unlikely given the time scale imposed by competing nucleotide excision repair. The XPD/ERCC2-defective UV5 cell line is as sensitive as XPF or ERCC1 mutants to bulky DNA monoadducts, with HF values in the order of 5-to 7-fold (33, 40, 41) as confirmed in the present study using nitracrine (Supplementary Table S3 ) 4 and the half mustard (monoalkylating) analogue of chlorambucil (Supplementary Table S2 ). 4 However, UV5 cells did not show significant hypersensitivity to PR-104A, or indeed to its half mustard analogues, which we used as model compounds for the non-cross-linking toxicity of PR-104A (Fig. 3) . In addition, the cytotoxic potency of the half mustards was not greatly different from the diethyl analogue (3, Fig. 1 ), which is incapable of monoalkylation.
Taken together, these observations suggest that a nonalkylating (and possibly a nongenotoxic) mechanism is likely to be responsible for the cytotoxicity of the dinitrobenzamide half mustards (1 and 2) and the ethyl analogue (3) and that this same mechanism might contribute to PR-104A cytotoxicity under aerobic conditions. A plausible mechanism is redox cycling as a result of reoxidation of a PR-104A nitro radical by oxygen. This would be consistent with the observed selectivity of the half mustard and diethyl analogues for oxic conditions (Fig. 1B) . It is also consistent with the modestly increased aerobic cytotoxicity of PR-104A on transfection of 51D +/+ or 51D −/− cells with sCYPOR (Fig. 5C ), which would increase the rate of any such futile redox cycling. However, we cannot exclude the possibility that this modest increase in aerobic cytotoxicity reflects the slight increase in PR-104H and PR-104M levels seen in the sCYPOR-transfected cells (Fig. 4C) . The lack of a "repair signature" for the dinitrobenzamide half mustards in the present cell line panel (which evaluates NER, NHEJ, and HRR) means that other approaches will be needed to identify conclusively the non-ICL mechanism of PR-104A cytotoxicity. However, this mechanism is less likely to be important at pharmacologically achievable PR-104A exposures, at least in the intended hypoxic target cells for PR-104.
Although the present study has investigated only effects of acute hypoxia, chronic hypoxia is likely to additionally sensitize to PR-104A through the translational downregulation of HRR proteins such as Rad51 (50) . Thus, the determinants of bioreductive prodrug activation (hypoxia and reductase activity) and ICL repair phenotype (reflecting both genetic changes and environmental stresses in tumors) are expected to interact to determine cellular sensitivity to PR-104A. Each of these factors will need to be evaluated critically during the clinical development of PR-104. 
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